Your session is about to expire
← Back to Search
Observational for Soft Tissue Sarcoma
N/A
Recruiting
Led By Matthew T. Houdek, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Summary
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Eligible Conditions
- Bone Sarcoma
- Soft Tissue Sarcoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accuracy of intraoperative ICG fluorescence compared to final pathology results
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients receive ICG infusion prior to undergoing scheduled resection and have medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,356 Total Patients Enrolled
Matthew T. Houdek, M.D.Principal InvestigatorMayo Clinic in Rochester
Share this study with friends
Copy Link
Messenger